Male gender is associated with deficit schizophrenia: a meta-analysis

https://doi.org/10.1016/S0920-9964(99)00231-5Get rights and content

Abstract

An association between deficit schizophrenia and male gender could be expected, since male schizophrenic subjects have been repeatedly found more severe than females on several dimensions of severity. Surprisingly, very few studies have confirmed such an association. We performed a more definitive test of this association using a meta-analysis. A pooled odds ratio was computed based on the 23 studies that reported the gender ratio in deficit vs. non-deficit schizophrenia. We tested for the heterogeneity of the association and examined the potential impact of the sampling method, the method used to assess the deficit syndrome, the breadth of diagnoses included and the mean duration of illness. A highly significant association between male gender and deficit schizophrenia was observed (pooled odds ratio=1.75). There was no definitive evidence that differences across studies in sampling methods, breadth of diagnoses included, mean duration of illness and methods to assess the deficit syndrome affected the strength of the association. However, the studies using the ‘Proxy Deficit Syndrome’ method to assess the deficit syndrome yielded qualitatively weaker evidence. This significant association between male gender and deficit schizophrenia may reflect the influence of a gender related factor (e.g. sexual hormones) or gender differences in the liability to different etiologies of schizophrenia. The role of gender as a potential confounder must be closely examined in studies comparing deficit and non-deficit SZ .

Introduction

Carpenter et al (Carpenter et al., 1988, Kirkpatrick et al., 1989) defined deficit schizophrenia (SZ) by the presence of at least two out of six negative symptoms for at least 12 months. In addition, these symptoms could not be explained by anxiety, psychosis, neuroleptic side-effects, concurrent depression or other causes. A very high degree of temporal stability of this distinction has been documented in at least two studies (Amador et al., 1999, Fenton and McGlashan, 1994), and it has been found not to be confounded by neuroleptic side-effects (Bustillo et al., 1995). Among several differences that have been observed between deficit and non-deficit SZ, the poorer outcome and the poorer premorbid adjustment in deficit SZ are probably the best replicated (see Roy et al., in press, for a review). Since male SZ subjects have been repeatedly found to have a poorer outcome and poorer premorbid adjustment than their female counterparts (Castle and Murray, 1991, Hafner and An Der Helden, 1997), an association between deficit SZ and male gender could be speculated. Surprisingly, in a recent review on the validity of deficit vs. non-deficit SZ subtypes (Roy et al., in press), we found no consistent evidence across studies for such an association, although several studies reported an overproportion of males in deficit SZ that did not reach statistical significance in most instances. Consequently, it is possible that these studies did not have sufficient statistical power individually to yield significant evidence for such an association. The present paper used meta-analytic techniques to determine whether pooling these studies would yield significant gender ratio differences in deficit vs. non-deficit SZ.

Section snippets

Selection criteria

Articles reporting gender ratio in deficit vs. non-deficit SZ subgroups were identified through medline searches, bibliographies of published articles and contacts with one of the developers of these subtypes (Dr Brian Kirkpatrick). The use of Carpenter et al.'s criteria (Carpenter et al., 1988, Kirkpatrick et al., 1989) to define deficit vs. non-deficit subtypes was required to include any study in the meta-analysis.

Statistical analyses

For each study, an odds ratio (OR) was computed. Then, each of the studies was

Results

We identified 23 studies (listed in Table 1) that met our selection criteria. In two additional studies (Nibuya et al., 1995, Wagman et al., 1987), deficit and non-deficit SZ were paired for gender, and in three additional studies (Buchanan et al., 1998, Loas et al., 1996, Thaker et al., 1989), gender ratios were not provided, which prevented the inclusion of these five studies. The 23 studies meeting our selection criteria involved a total of 1765 patients. The global proportion of deficit

Methodological issues

This meta analysis provides strong empirical support for an association between male gender and deficit SZ. In addition, although a few studies yielded ORs that appeared qualitatively larger than that of other studies (i.e. ORs >5), we found no definitive evidence for significant heterogeneity across studies in the strength of this association despite the use of five complementary strategies. First, the Breslow–Day test yielded no evidence of heterogeneity. Second, the strength of the

Acknowledgments

Supported by grants from Medical Research Council of Canada, Health and Welfare Canada, EJLB Foundation and Fonds de la recherche en santé du Québec (FRSQ). Marc-André Roy and Chantal Mérette are supported by FRSQ scientist awards.

References (43)

  • M. Nibuya et al.

    Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement

    Biol. Psychiatry

    (1995)
  • F. Thibaut et al.

    Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia

    Biol. Psychiatry

    (1998)
  • B.I. Turetsky et al.

    P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology

    Biol. Psychiatry

    (1998)
  • A.M.I. Wagman et al.

    Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation

    Psychiatry Res.

    (1987)
  • R.W. Waltrip et al.

    Borna disease antibodies and the deficit syndrome of schizophrenia

    Schizophr. Res.

    (1997)
  • X.F. Amador et al.

    Stability of the diagnosis of deficit syndrome in schizophrenia

    Am. J. Psychiatry

    (1999)
  • R.W. Buchanan et al.

    Clinical correlates of the deficit syndrome of schizophrenia

    Am. J. Psychiatry

    (1990)
  • R.W. Buchanan et al.

    Structural abnormalities in deficit and nondeficit schizophrenia

    Am. J. Psychiatry

    (1993)
  • R.W. Buchanan et al.

    Neuropsychological impairments deficit vs. nondeficit forms of schizophrenia

    Arch. Gen. Psychiatry

    (1994)
  • R.W. Buchanan et al.

    Attentional impairments in deficit and nondeficit forms of schizophrenia

    Am. J. Psychiatry

    (1997)
  • R.W. Buchanan et al.

    Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome

    Am. J. Psychiatry

    (1998)
  • Cited by (95)

    • Risk factors of deficit and non-deficit schizophrenia: Results from a cross-sectional study

      2022, Revista de Psiquiatria y Salud Mental
      Citation Excerpt :

      Nevertheless, both studies indicate that early and late risk factors might be differentially associated with the development of SCZ-D and SCZ-ND and are in line with some previous studies. The predominance of males among individuals with SCZ-D has been documented by meta-analysis, also showing qualitatively stronger evidence for studies based on the use of SDS.14 This observation points to a number of sex differences reported in patients with schizophrenia.

    • Early versus late risk factors for deficit and nondeficit schizophrenia

      2022, Revista de Psiquiatria y Salud Mental
      Citation Excerpt :

      Our sample size (n = 167) may also have contributed to the lack of replication of some risk factors. Male gender or advanced paternal age did not reach statistical significance (p = 0.30 and p = 0.38, respectively), although trend directions were in concordance with prior DS literature.7,21,40 Indeed, power calculations suggest a potential type II statistical error.

    View all citing articles on Scopus
    View full text